The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for JP Morgan Asset Management (UK) Ltd & Others
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Multiple JP Morgan Asset Management entities (funds managed by JP Morgan UK, J.P. Morgan Investment Management Inc., JPMorgan Chase Bank, and JP Morgan Asia Pacific/Singapore) disclosed a sale of 3,43,968 shares (0.66%) of Metropolis Healthcare on 27 June 2025 through the open market. This brought their aggregate holding down from 19,77,626 shares (3.82%) to 16,33,658 shares (3.15%) of the company. The acquirer group is not part of the promoter/promoter group. The filing notes that the combined JP Morgan holding has declined from a previously disclosed 5.68% to 3.15%, indicating a broader phased exit.
A meaningful reduction by a large foreign institutional investor like JP Morgan may exert mild short-term selling pressure on the stock and signals reduced foreign fund conviction. However, the overall FII presence in Metropolis remains active and the stake sold is relatively small in absolute terms.